Cargando…

In vitro assay by bioengineering of new antiviral drugs

Detalles Bibliográficos
Autores principales: Tashuta, Viktor, Klestova, Zinaida, Voronina, Alla, Dgebuadze, Shota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485177/
http://dx.doi.org/10.1016/j.nbt.2014.05.1888
_version_ 1784577483716165632
author Tashuta, Viktor
Klestova, Zinaida
Voronina, Alla
Dgebuadze, Shota
author_facet Tashuta, Viktor
Klestova, Zinaida
Voronina, Alla
Dgebuadze, Shota
author_sort Tashuta, Viktor
collection PubMed
description
format Online
Article
Text
id pubmed-8485177
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84851772021-10-01 In vitro assay by bioengineering of new antiviral drugs Tashuta, Viktor Klestova, Zinaida Voronina, Alla Dgebuadze, Shota N Biotechnol Pe-12 Published by Elsevier B.V. 2014-07 2014-07-10 /pmc/articles/PMC8485177/ http://dx.doi.org/10.1016/j.nbt.2014.05.1888 Text en Copyright © 2014 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Pe-12
Tashuta, Viktor
Klestova, Zinaida
Voronina, Alla
Dgebuadze, Shota
In vitro assay by bioengineering of new antiviral drugs
title In vitro assay by bioengineering of new antiviral drugs
title_full In vitro assay by bioengineering of new antiviral drugs
title_fullStr In vitro assay by bioengineering of new antiviral drugs
title_full_unstemmed In vitro assay by bioengineering of new antiviral drugs
title_short In vitro assay by bioengineering of new antiviral drugs
title_sort in vitro assay by bioengineering of new antiviral drugs
topic Pe-12
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485177/
http://dx.doi.org/10.1016/j.nbt.2014.05.1888
work_keys_str_mv AT tashutaviktor invitroassaybybioengineeringofnewantiviraldrugs
AT klestovazinaida invitroassaybybioengineeringofnewantiviraldrugs
AT voroninaalla invitroassaybybioengineeringofnewantiviraldrugs
AT dgebuadzeshota invitroassaybybioengineeringofnewantiviraldrugs